Show simple item record

dc.contributor.authorKastinen, Meeri
dc.contributor.authorSirniö, Päivi
dc.contributor.authorElomaa, Hanna
dc.contributor.authorÄijälä, Ville K.
dc.contributor.authorKarjalainen, Henna
dc.contributor.authorTapiainen, Vilja V.
dc.contributor.authorPohjanen, Vesa-Matti
dc.contributor.authorKemppainen, Janette
dc.contributor.authorSliashynskaya, Katja
dc.contributor.authorAhtiainen, Maarit
dc.contributor.authorRintala, Jukka
dc.contributor.authorMeriläinen, Sanna
dc.contributor.authorRautio, Tero
dc.contributor.authorSaarnio, Juha
dc.contributor.authorMattila, Taneli T.
dc.contributor.authorLindgren, Outi
dc.contributor.authorWirta, Erkki-Ville
dc.contributor.authorHelminen, Olli
dc.contributor.authorSeppälä, Toni T.
dc.contributor.authorBöhm, Jan
dc.contributor.authorMecklin, Jukka-Pekka
dc.contributor.authorTuomisto, Anne
dc.contributor.authorMäkinen, Markus J.
dc.contributor.authorVäyrynen, Juha P.
dc.date.accessioned2024-08-02T11:19:56Z
dc.date.available2024-08-02T11:19:56Z
dc.date.issued2024
dc.identifier.citationKastinen, M., Sirniö, P., Elomaa, H., Äijälä, V. K., Karjalainen, H., Tapiainen, V. V., Pohjanen, V.-M., Kemppainen, J., Sliashynskaya, K., Ahtiainen, M., Rintala, J., Meriläinen, S., Rautio, T., Saarnio, J., Mattila, T. T., Lindgren, O., Wirta, E.-V., Helminen, O., Seppälä, T. T., . . . Väyrynen, J. P. (2024). Establishing Criteria for Tumor Necrosis as Prognostic Indicator in Colorectal Cancer. <i>American Journal of Surgical Pathology</i>, <i>Early online</i>. <a href="https://doi.org/10.1097/PAS.0000000000002286" target="_blank">https://doi.org/10.1097/PAS.0000000000002286</a>
dc.identifier.otherCONVID_221130596
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/96502
dc.description.abstractTumor necrosis has been reported to represent an independent prognostic factor in colorectal cancer, but its evaluation methods have not been described in sufficient detail to introduce tumor necrosis evaluation into clinical use. To study the potential of tumor necrosis as a prognostic indicator in colorectal cancer, criteria for 3 methods for its evaluation were defined: the average percentage method (tumor necrosis percentage of the whole tumor), the hotspot method (tumor necrosis percentage in a single hotspot), and the linear method (the diameter of the single largest necrotic focus). Cox regression models were used to calculate cancer-specific mortality hazard ratios (HRs) for tumor necrosis categories in 2 colorectal cancer cohorts with more than 1800 cases. For reproducibility assessment, 30 cases were evaluated by 9 investigators, and Spearman’s rank correlation coefficients and Cohen’s kappa coefficients were calculated. We found that all 3 methods predicted colorectal cancer-specific survival independent of other prognostic parameters, including disease stage, lymphovascular invasion, and tumor budding. The greatest multivariable HRs were observed for the average percentage method (cohort 1: HR for ≥ 40% vs. <3% 3.03, 95% CI, 1.93-4.78; cohort 2: HR for ≥ 40% vs. < 3% 2.97; 95% CI, 1.63-5.40). All 3 methods had high reproducibility, with the linear method showing the highest mean Spearman’s correlation coefficient (0.91) and Cohen’s kappa (0.70). In conclusion, detailed criteria for tumor necrosis evaluation were established. All 3 methods showed good reproducibility and predictive ability. The findings pave the way for the use of tumor necrosis as a prognostic factor in colorectal cancer.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherOvid Technologies (Wolters Kluwer Health)
dc.relation.ispartofseriesAmerican Journal of Surgical Pathology
dc.rightsCC BY 4.0
dc.titleEstablishing Criteria for Tumor Necrosis as Prognostic Indicator in Colorectal Cancer
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202408025323
dc.contributor.laitosBio- ja ympäristötieteiden laitosfi
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosDepartment of Biological and Environmental Scienceen
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn0147-5185
dc.relation.volumeEarly online
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysopaksusuolisyöpä
dc.subject.ysokasvaimet
dc.subject.ysonekroosi
dc.subject.ysoennusteet
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p5937
jyx.subject.urihttp://www.yso.fi/onto/yso/p2299
jyx.subject.urihttp://www.yso.fi/onto/yso/p40084
jyx.subject.urihttp://www.yso.fi/onto/yso/p3297
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1097/PAS.0000000000002286
jyx.fundinginformationThis study was funded by Cancer Foundation Finland (59-5619 to J.P.V.), Finnish Medical Foundation (6021 to J.P.V.; 6259 to M.K.), Oulu Medical Research Foundation (to M.K.), Sigrid Jusélius Foundation (230229 to J.P.V.), and Finnish State Research Funding (to M.J.M. and J.P.V.).
dc.type.okmA1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0